ACS Chemical Biology · 2013 · 110 citations · 36 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyLigand BindingMolecular DockingProtein-ligand DockingReceptor ModelingReceptor PharmacologyReceptor-ligand InteractionsAdrenergic Receptor AgonistsConformational Flexibility Of ReceptorsDopamine D2-like ReceptorsG Protein-coupled Receptor ModelingG Protein-coupled Receptor Structure-function RelationshipsLigand Design For ReceptorsMolecular Conformation AnalysisMolecular Conformation Prediction
A prospective, large library virtual screen against an activated β2-adrenergic receptor (β2AR) structure returned potent agonists to the exclusion of inverse-agonists, providing the first complement to the previous virtual screening campaigns against inverse-agonist-bound G protein coupled receptor (GPCR) structures, which predicted only inverse-agonists. In addition, two hits recapitulated the signaling profile of the co-crystal ligand with respect to the G protein and arrestin mediated signaling. This functional fidelity has important implications in drug design, as the ability to predict ligands with predefined signaling properties is highly desirable. However, the agonist-bound state provides an uncertain template for modeling the activated conformation of other GPCRs, as a dopamine D2 receptor (DRD2) activated model templated on the activated β2AR structure returned few hits of only marginal potency.
36
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton, Louisa J. Bellis, A. Patrícia Bento et al. · Nucleic Acids Research · 2011 · 4.5K citations · Full text
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Søren G. F. Rasmussen, Brian T. DeVree, Yaozhong Zou et al. · Nature · 2011 · 3.1K citations · Full text
ZINC: A Free Tool to Discover Chemistry for Biology
John J. Irwin, Teague Sterling, Michael M. Mysinger et al. · Journal of Chemical Information and Modeling · 2012 · 2.6K citations · Full text